Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Whole-brain radiotherapy in primary CNS lymphoma.
Ferreri AJ, DeAngelis L, Illerhaus G, O'Neill BP, Reni M, Soussain C, Yahalom J. Ferreri AJ, et al. Among authors: reni m. Lancet Oncol. 2011 Feb;12(2):118-9; author reply 119-20. doi: 10.1016/S1470-2045(11)70018-3. Lancet Oncol. 2011. PMID: 21277546 No abstract available.
Establishing a prognostic score for primary CNS lymphomas.
Ferreri AJ, Reni M. Ferreri AJ, et al. Among authors: reni m. Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):303-4; author reply 304-5. doi: 10.1016/j.ijrobp.2004.09.053. Int J Radiat Oncol Biol Phys. 2005. PMID: 15629627 No abstract available.
Primary central nervous system lymphoma.
Ferreri AJ, Reni M. Ferreri AJ, et al. Among authors: reni m. Crit Rev Oncol Hematol. 2007 Sep;63(3):257-68. doi: 10.1016/j.critrevonc.2007.04.012. Epub 2007 Jun 21. Crit Rev Oncol Hematol. 2007. PMID: 17590348 Review.
Primary CNS lymphomas prognosis.
Ferreri AJ, Reni M, Zucca E, Cavalli F. Ferreri AJ, et al. Among authors: reni m. J Clin Oncol. 2007 Sep 20;25(27):4322-4; author reply 4324-5. doi: 10.1200/JCO.2007.12.1285. J Clin Oncol. 2007. PMID: 17878489 No abstract available.
Primary central nervous system lymphoma: biological aspects and controversies in management.
Bessell EM, Hoang-Xuan K, Ferreri AJ, Reni M. Bessell EM, et al. Among authors: reni m. Eur J Cancer. 2007 May;43(7):1141-52. doi: 10.1016/j.ejca.2006.12.011. Epub 2007 Apr 12. Eur J Cancer. 2007. PMID: 17433666 Review.
Andres Ferreri) as well as controversies in the use of whole brain radiotherapy (WBRT) after chemotherapy (Dr. Michele Reni). The topics covered with discussants at the workshop are also summarised. ...The importance of high dose methotrexate (HDMTX; dose > or = 1g/m …
Andres Ferreri) as well as controversies in the use of whole brain radiotherapy (WBRT) after chemotherapy (Dr. Michele Reni). The top …
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.
Ferreri AJ, Reni M, Foppoli M, Martelli M, Pangalis GA, Frezzato M, Cabras MG, Fabbri A, Corazzelli G, Ilariucci F, Rossi G, Soffietti R, Stelitano C, Vallisa D, Zaja F, Zoppegno L, Aondio GM, Avvisati G, Balzarotti M, Brandes AA, Fajardo J, Gomez H, Guarini A, Pinotti G, Rigacci L, Uhlmann C, Picozzi P, Vezzulli P, Ponzoni M, Zucca E, Caligaris-Cappio F, Cavalli F; International Extranodal Lymphoma Study Group (IELSG). Ferreri AJ, et al. Among authors: reni m. Lancet. 2009 Oct 31;374(9700):1512-20. doi: 10.1016/S0140-6736(09)61416-1. Epub 2009 Sep 18. Lancet. 2009. PMID: 19767089 Free article. Clinical Trial.
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Ferreri AJ, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, Fox CP, Rosée PL, Schorb E, Ambrosetti A, Roth A, Hemmaway C, Ferrari A, Linton KM, Rudà R, Binder M, Pukrop T, Balzarotti M, Fabbri A, Johnson P, Gørløv JS, Hess G, Panse J, Pisani F, Tucci A, Stilgenbauer S, Hertenstein B, Keller U, Krause SW, Levis A, Schmoll HJ, Cavalli F, Finke J, Reni M, Zucca E, Illerhaus G; International Extranodal Lymphoma Study Group (IELSG). Ferreri AJ, et al. Among authors: reni m. Lancet Haematol. 2016 May;3(5):e217-27. doi: 10.1016/S2352-3026(16)00036-3. Epub 2016 Apr 6. Lancet Haematol. 2016. PMID: 27132696 Clinical Trial.
276 results